These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 30788916

  • 1. [The improvement effect of scFv17 on the gait of triple-transgenic mice].
    Wang T, Cao Y, Hu MM, Zhang XM, Dong XF, Qi JS, Zhang J, Yang W.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 May 08; 34(5):389-395. PubMed ID: 30788916
    [Abstract] [Full Text] [Related]

  • 2. Motor deficits in 16-month-old male and female 3xTg-AD mice.
    Garvock-de Montbrun T, Fertan E, Stover K, Brown RE.
    Behav Brain Res; 2019 Jan 01; 356():305-313. PubMed ID: 30208295
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J, Lebbadi M, Tremblay C, St-Amour I, Pierrisnard C, Faucher-Genest A, Emond V, Julien C, Calon F.
    Synapse; 2018 Apr 01; 72(4):. PubMed ID: 29341269
    [Abstract] [Full Text] [Related]

  • 4. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
    Kong V, Devenyi GA, Gallino D, Ayranci G, Germann J, Rollins C, Chakravarty MM.
    Brain Struct Funct; 2018 Sep 01; 223(7):3365-3382. PubMed ID: 29948190
    [Abstract] [Full Text] [Related]

  • 5. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Shishido H, Kishimoto Y, Kawai N, Toyota Y, Ueno M, Kubota T, Kirino Y, Tamiya T.
    Neurosci Lett; 2016 Aug 26; 629():62-67. PubMed ID: 27373531
    [Abstract] [Full Text] [Related]

  • 6. Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer's disease.
    St-Amour I, Bosoi CR, Paré I, Ignatius Arokia Doss PM, Rangachari M, Hébert SS, Bazin R, Calon F.
    J Neuroinflammation; 2019 Jan 05; 16(1):3. PubMed ID: 30611289
    [Abstract] [Full Text] [Related]

  • 7. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A.
    Neurodegener Dis; 2010 Jan 05; 7(6):379-88. PubMed ID: 20689242
    [Abstract] [Full Text] [Related]

  • 8. [Chronic sleep deprivation exacerbates cognitive and pathological impairments in APP/PS1/tau triple transgenic Alzheimer's disease model mice].
    Wang C, Cao X, Yin J, Gao WR, Li WR, Qi JS, Wu MN.
    Sheng Li Xue Bao; 2021 Jun 25; 73(3):471-481. PubMed ID: 34230948
    [Abstract] [Full Text] [Related]

  • 9. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D, Ottani A, Zaffe D, Galantucci M, Strinati F, Lodi R, Guarini S.
    Neurobiol Learn Mem; 2013 Sep 25; 104():82-91. PubMed ID: 23726868
    [Abstract] [Full Text] [Related]

  • 10. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A, Aoyama Y, Shin EJ, Nam Y, Kim HC, Nagai T, Yokosuka A, Mimaki Y, Yokoi T, Ohizumi Y, Yamada K.
    Behav Brain Res; 2015 Aug 01; 289():69-77. PubMed ID: 25913833
    [Abstract] [Full Text] [Related]

  • 11. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
    Ontiveros-Torres MÁ, Labra-Barrios ML, Díaz-Cintra S, Aguilar-Vázquez AR, Moreno-Campuzano S, Flores-Rodríguez P, Luna-Herrera C, Mena R, Perry G, Florán-Garduño B, Luna-Muñoz J, Luna-Arias JP.
    J Alzheimers Dis; 2016 Mar 22; 52(1):243-69. PubMed ID: 27031470
    [Abstract] [Full Text] [Related]

  • 12. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.
    Perez SE, He B, Muhammad N, Oh KJ, Fahnestock M, Ikonomovic MD, Mufson EJ.
    Neurobiol Dis; 2011 Feb 22; 41(2):338-52. PubMed ID: 20937383
    [Abstract] [Full Text] [Related]

  • 13. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A, Dudonné S, Bourassa P, Bourdoulous M, Tremblay C, Desjardins Y, Calon F, Neurophenols consortium.
    J Alzheimers Dis; 2017 Feb 22; 55(1):115-135. PubMed ID: 27662290
    [Abstract] [Full Text] [Related]

  • 14. [Effects of adiponectin on the anxiety and memory impairment in triple transgenic Alzheimer's disease model mice].
    Qu XS, Shi H, Cao XL, Dong XF, Li T, Jiao JJ, Qi JS, Wu MN.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May 08; 33(5):405-409. PubMed ID: 29926583
    [Abstract] [Full Text] [Related]

  • 15. Reduction of amyloid beta by Aβ3-10-KLH vaccine also decreases tau pathology in 3×Tg-AD mice.
    Zhang HY, Zhu K, Meng Y, Ding L, Wang JC, Yin WC, Yan Y, Cao YP.
    Brain Res Bull; 2018 Sep 08; 142():233-240. PubMed ID: 30077729
    [Abstract] [Full Text] [Related]

  • 16. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
    Baglietto-Vargas D, Kitazawa M, Le EJ, Estrada-Hernandez T, Rodriguez-Ortiz CJ, Medeiros R, Green KN, LaFerla FM.
    Neurobiol Dis; 2014 Feb 08; 62():407-15. PubMed ID: 24176788
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    ACS Chem Neurosci; 2017 Mar 15; 8(3):676-685. PubMed ID: 28032988
    [Abstract] [Full Text] [Related]

  • 18. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Mar 15; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 19. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
    Bories C, Arsenault D, Lemire M, Tremblay C, De Koninck Y, Calon F.
    Aging (Albany NY); 2017 May 16; 9(5):1386-1403. PubMed ID: 28522792
    [Abstract] [Full Text] [Related]

  • 20. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    Neuropharmacology; 2018 Mar 15; 131():351-363. PubMed ID: 29309769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.